2026-06-30
No AI summary for this filing type
View Full Filing (SEC EDGAR)NVCR
NovoCure Limited
-$164.9M
Net Activity
Institutions Holding
220
Popularity Rank
#2649
Avg Weight
0.05%
Total Value
$1.1B
Ownership Trend
220 institutions currently hold NVCR, with 108 net buyers and 124 net sellers this quarter.
Institutional Moves
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
124
Net Buying Institutions
108
Key Holders
Key Holders
Top 5 by Value
Quarterly Activity
Recent Activity
+$617.5M
Total Buy Value
$544.8M
Total Sell Value
New buy30
Trim74
Add78
Sold out50
108
Net Buyers
124
Net Sellers
Insider Trading (Form 4)
Form 144 Pre-Sale Notices
1
Filings (90d)
$615K
Total Est. Value
34K shares
Planned Shares
Last Filed 2026-06-04
| Filer | Filing Date | Est. Value |
|---|---|---|
| Leonard Frank X | 2026-06-04 | $615K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
Beneficial Ownership (13D/13G)
No Schedule 13D/13G filings for this ticker
Material Events (8-K)
FAQ
Who are the top institutional investors holding NovoCure Limited (NVCR)?
Major stakeholders currently include FMR LLC ($186.1M), BlackRock, Inc. ($143.8M), Soleus Capital Management, L.P. ($114.4M). Based on the latest 13F filings, there are a total of 220 tracked investment funds and institutions maintaining positions in NVCR.
What is the overall institutional sentiment toward NVCR recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $164.9M, driven by 108 managers accumulating shares while 124 reduced their exposure.
Which institutions have been selling or reducing their NVCR positions?
In the latest period, 74 funds trimmed their holdings, and 50 managers completely exited their positions. The aggregate reported sell value was $544.8M.
Are there any notable investors adding NVCR to their portfolios?
Yes, buying activity remains notable. 30 institutions opened new positions in {ticker}, and 78 existing holders added to their shares. The total reported buy value for the quarter amounted to $617.5M.
Related Stocks
Same Sector
Other stocks in the same GICS sector
JNJ
Johnson & Johnson
Institutions Holding
4,603
Total reported value
$438.8B
193 institutions currently hold both NVCR and this stock
View detail
LLY
Eli Lilly & Co
Institutions Holding
4,337
Total reported value
$730.5B
204 institutions currently hold both NVCR and this stock
View detail
ABBV
Abbvie INC
Institutions Holding
4,024
Total reported value
$283.9B
196 institutions currently hold both NVCR and this stock
View detail
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter
MSFT
Microsoft CORP
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
View detail
AMZN
Amazon.com INC
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
View detail
NVDA
Nvidia CORP
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter
View detail